Michael Gibney

Michael Gibney
Michael Gibney

Michael Gbney is a former editor with the FierceMarkets Life Sciences group.

Stories by Michael Gibney

Myeloblasts with Auer rods seen in acute myeloid leukemia

New CRISPR tool disrupts gene in leukemia cells

CRISPR gene editing is a cutting-edge tool that is gaining more and more ground as a way to treat diseases. And as shown in a new study, researchers at the Wellcome Trust Sanger Institute have identified genes that could serve as targets to treat acute myeloid leukemia.